| T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial DW Lee, JN Kochenderfer, M Stetler-Stevenson, YK Cui, C Delbrook, ... The Lancet 385 (9967), 517-528, 2015 | 3124 | 2015 |
| Current concepts in the diagnosis and management of cytokine release syndrome DW Lee, R Gardner, DL Porter, CU Louis, N Ahmed, M Jensen, SA Grupp, ... Blood, The Journal of the American Society of Hematology 124 (2), 188-195, 2014 | 2768 | 2014 |
| Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1 PF Robbins, RA Morgan, SA Feldman, JC Yang, RM Sherry, ME Dudley, ... Journal of Clinical Oncology 29 (7), 917, 2011 | 1901 | 2011 |
| 4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors AH Long, WM Haso, JF Shern, KM Wanhainen, M Murgai, M Ingaramo, ... Nature medicine 21 (6), 581-590, 2015 | 1572 | 2015 |
| Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy CL Mackall, TA Fleisher, MR Brown, MP Andrich, CC Chen, IM Feuerstein, ... New England Journal of Medicine 332 (3), 143-149, 1995 | 1262 | 1995 |
| CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy TJ Fry, NN Shah, RJ Orentas, M Stetler-Stevenson, CM Yuan, ... Nature medicine 24 (1), 20-28, 2018 | 1230 | 2018 |
| Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy E Sotillo, DM Barrett, KL Black, A Bagashev, D Oldridge, G Wu, ... Cancer discovery 5 (12), 1282-1295, 2015 | 1188 | 2015 |
| Tumor antigen escape from CAR T-cell therapy RG Majzner, CL Mackall Cancer discovery 8 (10), 1219-1226, 2018 | 790 | 2018 |
| Disruption of CXCR2-mediated MDSC tumor trafficking enhances anti-PD1 efficacy SL Highfill, Y Cui, AJ Giles, JP Smith, H Zhang, E Morse, RN Kaplan, ... Science translational medicine 6 (237), 237ra67-237ra67, 2014 | 718 | 2014 |
| The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance TJ Fry, CL Mackall The Journal of Immunology 174 (11), 6571-6576, 2005 | 712 | 2005 |
| Anti-CD22–chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia W Haso, DW Lee, NN Shah, M Stetler-Stevenson, CM Yuan, IH Pastan, ... Blood, The Journal of the American Society of Hematology 121 (7), 1165-1174, 2013 | 662 | 2013 |
| Interleukin-7: from bench to clinic TJ Fry, CL Mackall Blood, The Journal of the American Society of Hematology 99 (11), 3892-3904, 2002 | 639 | 2002 |
| Harnessing the biology of IL-7 for therapeutic application CL Mackall, TJ Fry, RE Gress Nature Reviews Immunology 11 (5), 330-342, 2011 | 628 | 2011 |
| c-Jun overexpression in CAR T cells induces exhaustion resistance RC Lynn, EW Weber, E Sotillo, D Gennert, P Xu, Z Good, H Anbunathan, ... Nature 576 (7786), 293-300, 2019 | 559 | 2019 |
| Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets C Sportès, FT Hakim, SA Memon, H Zhang, KS Chua, MR Brown, ... The Journal of experimental medicine 205 (7), 1701-1714, 2008 | 547 | 2008 |
| A potential role for interleukin-7 in T-cell homeostasis TJ Fry, E Connick, J Falloon, MM Lederman, DJ Liewehr, J Spritzler, ... Blood, The Journal of the American Society of Hematology 97 (10), 2983-2990, 2001 | 526 | 2001 |
| IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cells SA Rosenberg, C Sportès, M Ahmadzadeh, TJ Fry, LT Ngo, SL Schwarz, ... Journal of immunotherapy 29 (3), 313-319, 2006 | 506 | 2006 |
| Thymic-independent T cell regeneration occurs via antigen-driven expansion of peripheral T cells resulting in a repertoire that is limited in diversity and prone to skewing. CL Mackall, CV Bare, LA Granger, SO Sharrow, JA Titus, RE Gress Journal of immunology (Baltimore, Md.: 1950) 156 (12), 4609-4616, 1996 | 489 | 1996 |
| Distinctions Between CD8+ and CD4+ T-Cell Regenerative Pathways Result in Prolonged T-Cell Subset Imbalance After Intensive Chemotherapy CL Mackall, TA Fleisher, MR Brown, MP Andrich, CC Chen, IM Feuerstein, ... Blood, The Journal of the American Society of Hematology 89 (10), 3700-3707, 1997 | 478 | 1997 |
| Lymphocyte depletion during treatment with intensive chemotherapy for cancer CL Mackall, TA Fleisher, MR Brown, IT Magrath, AT Shad, ME Horowitz, ... | 475 | 1994 |
